JP2018515556A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515556A5
JP2018515556A5 JP2017560309A JP2017560309A JP2018515556A5 JP 2018515556 A5 JP2018515556 A5 JP 2018515556A5 JP 2017560309 A JP2017560309 A JP 2017560309A JP 2017560309 A JP2017560309 A JP 2017560309A JP 2018515556 A5 JP2018515556 A5 JP 2018515556A5
Authority
JP
Japan
Prior art keywords
use according
disease
cancer
compound
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017560309A
Other languages
English (en)
Japanese (ja)
Other versions
JP6873919B2 (ja
JP2018515556A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/033933 external-priority patent/WO2016191427A1/en
Publication of JP2018515556A publication Critical patent/JP2018515556A/ja
Publication of JP2018515556A5 publication Critical patent/JP2018515556A5/ja
Priority to JP2021071253A priority Critical patent/JP7274521B2/ja
Application granted granted Critical
Publication of JP6873919B2 publication Critical patent/JP6873919B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017560309A 2015-05-27 2016-05-24 オートタキシン阻害剤とその使用 Active JP6873919B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021071253A JP7274521B2 (ja) 2015-05-27 2021-04-20 オートタキシン阻害剤とその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562167216P 2015-05-27 2015-05-27
US62/167,216 2015-05-27
PCT/US2016/033933 WO2016191427A1 (en) 2015-05-27 2016-05-24 Autotaxin inhibitors and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021071253A Division JP7274521B2 (ja) 2015-05-27 2021-04-20 オートタキシン阻害剤とその使用

Publications (3)

Publication Number Publication Date
JP2018515556A JP2018515556A (ja) 2018-06-14
JP2018515556A5 true JP2018515556A5 (cg-RX-API-DMAC10.html) 2019-06-27
JP6873919B2 JP6873919B2 (ja) 2021-05-19

Family

ID=57393709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017560309A Active JP6873919B2 (ja) 2015-05-27 2016-05-24 オートタキシン阻害剤とその使用
JP2021071253A Active JP7274521B2 (ja) 2015-05-27 2021-04-20 オートタキシン阻害剤とその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021071253A Active JP7274521B2 (ja) 2015-05-27 2021-04-20 オートタキシン阻害剤とその使用

Country Status (14)

Country Link
US (2) US10632104B2 (cg-RX-API-DMAC10.html)
EP (2) EP4026549A1 (cg-RX-API-DMAC10.html)
JP (2) JP6873919B2 (cg-RX-API-DMAC10.html)
KR (2) KR20240060887A (cg-RX-API-DMAC10.html)
CN (2) CN116059203A (cg-RX-API-DMAC10.html)
AU (4) AU2016268250B2 (cg-RX-API-DMAC10.html)
BR (1) BR122023011445B1 (cg-RX-API-DMAC10.html)
CA (1) CA2986759C (cg-RX-API-DMAC10.html)
EA (2) EA039684B1 (cg-RX-API-DMAC10.html)
ES (1) ES2915267T3 (cg-RX-API-DMAC10.html)
IL (2) IL280863B2 (cg-RX-API-DMAC10.html)
MX (2) MX2017015225A (cg-RX-API-DMAC10.html)
SG (1) SG10201911204WA (cg-RX-API-DMAC10.html)
WO (1) WO2016191427A1 (cg-RX-API-DMAC10.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20160654A1 (es) 2013-11-22 2016-07-15 Pharmakea Inc Compuestos de inhibidor de autotaxina
CN116059203A (zh) 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途
CN107021915A (zh) * 2017-04-27 2017-08-08 李亚庆 一种治疗妇科炎症的化合物及制备方法和应用
US20200208128A1 (en) * 2017-08-14 2020-07-02 Camp4 Therapeutics Corporation Methods of treating liver diseases
WO2019172651A1 (ko) 2018-03-06 2019-09-12 주식회사 엘지화학 편광판 및 이를 포함하는 화상 표시 장치
US20220047553A1 (en) * 2018-09-18 2022-02-17 Metacrine, Inc. Farnesoid x receptor agonists for the treatment of disease
CN117018202A (zh) * 2019-07-08 2023-11-10 上海交通大学医学院附属瑞金医院 趋化因子受体ccr6抑制剂在预防银屑病复发中的新应用
WO2023122762A1 (en) 2021-12-22 2023-06-29 Camp4 Therapeutics Corporation Modulation of gene transcription using antisense oligonucleotides targeting regulatory rnas
CN114767863B (zh) * 2022-04-29 2024-01-30 西北工业大学 一种enpp2基因或蛋白在调控结直肠癌细胞中的应用
AU2023265017A1 (en) * 2022-05-03 2024-12-12 Df 2024 Ip Acquisition, Llc Polymorphic and salt forms of the autotaxin inhibitor cudetaxestat
US20250281486A1 (en) * 2022-05-05 2025-09-11 The Trustees Of Indiana University Therapeutic strategies to manage facial contractures post injury
GR1010570B (el) 2022-12-22 2023-11-17 Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Α.Β.Ε.Ε., 4-(2-(4-((2,4-διοξοθειαζολιδιν-5-υλ)μεθυλ)φαινοξυ) παραγωγα με δραση αναστολης της αυτοταξινης
TW202502735A (zh) * 2023-03-02 2025-01-16 印度商吉德斯生命科學有限公司 新穎atx抑制劑
CN116159056A (zh) * 2023-03-09 2023-05-26 中南大学湘雅医院 一种氟非尼酮在制备非酒精性脂肪性肝炎药物中的应用
CN116239577A (zh) * 2023-03-27 2023-06-09 沈阳药科大学 一种制备Cudetaxestat的方法

Family Cites Families (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210574A (en) 1991-03-08 1993-05-11 Mita Industrial Co., Ltd. Photosensitive drum body-mounting mechanism including a drive coupling member with a coupling protrusion adapted to bite into the inner surface of the mechanism's photosensitive drum
US5186522A (en) 1991-09-24 1993-02-16 Midland Brake, Inc. Air dryer purge line
DE69316741T2 (de) 1992-11-10 1998-09-10 Caterpillar Inc Magnetventil
US5407368A (en) 1992-12-15 1995-04-18 Minnesota Mining And Manufacturing Company Electrode connector
US5761473A (en) 1993-01-08 1998-06-02 International Business Machines Corporation Method and system for increased instruction synchronization efficiency in a superscalar processsor system utilizing partial data dependency interlocking
US5564949A (en) 1995-01-05 1996-10-15 Thomas & Betts Corporation Shielded compact data connector
JP2664048B2 (ja) 1995-03-27 1997-10-15 科学技術庁金属材料技術研究所長 六フッ化二ケイ素の合成法
GB9514473D0 (en) 1995-07-14 1995-09-13 Glaxo Lab Sa Chemical compounds
CA2386750A1 (en) 1999-10-22 2001-05-03 Merck & Co. Inc. Pharmaceuticals for treating obesity
US6890933B1 (en) 2000-02-24 2005-05-10 President And Fellows Of Harvard College Kinesin inhibitors
AU2002213421A1 (en) 2000-10-03 2002-04-15 Lilly Icos Llc Condensed pyridoindole derivatives
BR0208790A (pt) 2001-04-11 2004-03-30 Idenix Cayman Ltd Fenilindoìs para o tratamento de hiv
DE60203529T2 (de) 2001-09-27 2006-03-16 F. Hoffmann-La Roche Ag Indolderivate als cox-ii-inhibitoren
US7528165B2 (en) 2001-12-13 2009-05-05 National Health Research Institutes Indole compounds
CA2495943C (en) 2002-08-29 2009-07-21 Merck & Co., Inc. Indoles having anti-diabetic activity
WO2004019869A2 (en) 2002-08-29 2004-03-11 Merck & Co., Inc. Indoles having anti-diabetic activity
AU2004240649A1 (en) 2003-05-19 2004-12-02 Irm, Llc Immunosuppressant compounds and compositions
EP1701940B1 (en) 2003-12-23 2008-05-28 H.Lundbeck A/S 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
WO2005111278A1 (ja) 2004-05-19 2005-11-24 Sumitomo Electric Industries, Ltd. Iii族窒化物半導体結晶およびその製造方法ならびにiii族窒化物半導体デバイス
KR101141650B1 (ko) 2004-09-30 2012-05-17 엘지전자 주식회사 매체접속제어 계층에서의 데이터 처리 방법 및 이동통신용단말
WO2006041961A1 (en) 2004-10-05 2006-04-20 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTHAND HUMAN SERVICES Arylthioindole tubulin polymerization inhibitors and methods of treating or preventing cancer using same
WO2007134169A2 (en) 2006-05-10 2007-11-22 Nuada, Llc Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
US20080319044A1 (en) 2004-11-01 2008-12-25 Nuada, Llc Compounds and Methods of Use Thereof
US20060270634A1 (en) 2005-05-06 2006-11-30 Miller Duane D Acetal phosphate-derived LPA mimics, PPARgamma activators, and autotaxin inhibitors
AR054394A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de 2- (1h-indolilsulfanil)-aril amina
WO2007041600A2 (en) 2005-10-03 2007-04-12 Luminescent Technologies, Inc. Mask-pattern determination using topology types
ATE526318T1 (de) * 2005-12-19 2011-10-15 Glaxosmithkline Llc Farnesoid-x-rezeptor-agonisten
WO2008157361A1 (en) 2007-06-15 2008-12-24 University Of Utah Research Foundation α-CHLORO AND α-BROMO PHOSPHONATE ANALOGS OF LYSOPHOSPHATIDIC ACID AND METHODS OF MAKING AND USING THEREOF
DE102007047737A1 (de) 2007-10-05 2009-04-30 Merck Patent Gmbh Piperidin- und Piperazinderivate
DE102007047738A1 (de) 2007-10-05 2009-04-09 Merck Patent Gmbh Imidazolderivate
DE102007047735A1 (de) 2007-10-05 2009-04-09 Merck Patent Gmbh Thiazolderivate
US8268891B1 (en) 2007-11-13 2012-09-18 University Of Memphis Research Foundation Autotaxin inhibitors
US8378100B2 (en) 2008-01-09 2013-02-19 University Of Virginia Patent Foundation Phosphonate derivatives as autotaxin inhibitors
US20110110886A1 (en) 2008-06-13 2011-05-12 Yale University Small molecule inhibitors of autotaxin and methods of use
WO2010040080A1 (en) 2008-10-03 2010-04-08 Abby Louise Parrill-Baker Mechanism-based inactivators of autotaxin
DE102008059578A1 (de) 2008-11-28 2010-06-10 Merck Patent Gmbh Benzo-Naphtyridin Verbindungen
US8530650B2 (en) 2008-12-01 2013-09-10 Merck Patent Gmbh 2, 5-diamino-substituted pyrido [4, 3-D] pyrimidines as autotaxin inhibitors against cancer
JP5767205B2 (ja) 2009-04-02 2015-08-19 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung オートタキシン阻害剤としての複素環式化合物
US8329907B2 (en) 2009-04-02 2012-12-11 Merck Patent Gmbh Autotaxin inhibitors
AU2010234087B2 (en) 2009-04-02 2016-05-12 Merck Patent Gmbh Piperidine and piperazine derivatives as autotaxin inhibitors
US8445200B2 (en) * 2009-04-15 2013-05-21 The Regents Of The University Of California Genotoxicity as a biomarker for inflammation
CN102481269B (zh) 2009-05-11 2015-10-07 博格有限责任公司 包含辅酶q10的药物组合物及其制备方法
JP2010267037A (ja) 2009-05-14 2010-11-25 Fujitsu Ltd ディスクアレイ装置
CA2763016C (en) 2009-05-20 2018-04-17 Eth Zurich Targeting micrornas for metabolic disorders
WO2011002918A1 (en) 2009-06-30 2011-01-06 The University Of Memphis Research Foundation Novel diverse lead compound autotaxin inhibitors
DE102009033392A1 (de) 2009-07-16 2011-01-20 Merck Patent Gmbh Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
DE102009049211A1 (de) 2009-10-13 2011-04-28 Merck Patent Gmbh Sulfoxide
WO2011049433A1 (en) * 2009-10-23 2011-04-28 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Diagnosis and treatment of pruritis
WO2011053597A1 (en) 2009-10-26 2011-05-05 The University Of Memphis Research Foundation Pipemidic acid derivative autotaxin inhibitors
US8497371B2 (en) 2009-10-26 2013-07-30 University Of Memphis Research Foundation Pipemidic acid derivative autotaxin inhibitors
US9187471B2 (en) 2010-02-19 2015-11-17 Medivation Technologies, Inc. Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
WO2011116867A1 (de) 2010-03-26 2011-09-29 Merck Patent Gmbh Benzonaphthyridinamine als autotaxin-inhibitoren
CA2796459C (en) 2010-04-16 2016-05-24 Salk Institute For Biological Studies Methods for treating metabolic disorders using fgf-1
EP2606031B1 (en) 2010-08-20 2017-09-27 Amira Pharmaceuticals, Inc. Autotaxin inhibitors and uses thereof
US8771696B2 (en) 2010-11-23 2014-07-08 Regeneron Pharmaceuticals, Inc. Method of reducing the severity of stress hyperglycemia with human antibodies to the glucagon receptor
US8673882B2 (en) 2011-01-20 2014-03-18 University Of Tennessee Research Foundation Inhibitors of autotaxin
WO2012112964A2 (en) 2011-02-18 2012-08-23 Medivation Technologies, Inc. PYRIDO[4,3-b]INDOLE AND PYRIDO[3,4-b]INDOLE DERIVATIVES AND METHODS OF USE
CA2829045A1 (en) 2011-02-18 2012-08-23 Medivation Technologies, Inc. Compounds and methods for treatment of hypertension
WO2012123938A1 (en) * 2011-03-17 2012-09-20 Tel Hashomer Medical Research Infrastructure And Services Ltd. Quinolone analogs for treating autoimmune diseases
US9260416B2 (en) * 2011-05-27 2016-02-16 Amira Pharmaceuticals, Inc. Heterocyclic autotaxin inhibitors and uses thereof
GB2494154B (en) 2011-08-31 2017-11-29 Metaswitch Networks Ltd Conditional telecommunications
KR20130029948A (ko) 2011-09-16 2013-03-26 현대중공업 주식회사 용접 캐리지 이동용 가이드레일
WO2013054185A1 (en) 2011-10-13 2013-04-18 Pfizer, Inc. Pyrimidine and pyridine derivatives useful in therapy
EP3243815B1 (en) 2011-10-28 2019-07-10 Inhibitaxin Limited Pyridazine derivatives useful in therapy
JP2013129632A (ja) 2011-12-22 2013-07-04 Ono Pharmaceut Co Ltd Enpp2阻害化合物
US20130270634A1 (en) 2012-04-12 2013-10-17 Richtek Technology Corporation High voltage device and manufacturing method thereof
SI2861566T1 (sl) 2012-06-13 2017-03-31 F. Hoffmann-La Roche Ag Novi diazaspirocikloalkan in azaspirocikloalkan
WO2014031170A1 (en) 2012-08-22 2014-02-27 Medivation Technologies, Inc. Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
PL2900669T3 (pl) 2012-09-25 2020-01-31 F. Hoffmann-La Roche Ag Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek
EP2935249B1 (en) 2012-12-19 2018-12-12 Novartis AG Autotaxin inhibitors
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
TWI499591B (zh) 2013-01-11 2015-09-11 Lilly Co Eli 雙環嘧啶化合物
EP3046909A4 (en) 2013-09-17 2017-03-29 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
US9714240B2 (en) 2013-09-17 2017-07-25 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
US9850203B2 (en) * 2013-09-26 2017-12-26 Pharmakea, Inc. Autotaxin inhibitor compounds
HRP20181290T1 (hr) 2013-11-05 2018-10-19 Bayer Cropscience Aktiengesellschaft Novi spojevi za suzbijanje člankonožaca
EA201600403A1 (ru) 2013-11-22 2016-10-31 Басф Се N-ацилиминогетероциклические соединения
PE20160654A1 (es) 2013-11-22 2016-07-15 Pharmakea Inc Compuestos de inhibidor de autotaxina
CA2930735A1 (en) 2013-11-22 2015-05-28 Sabre Therapeutics Llc Tetracyclic autotaxin inhibitors
CL2016001118A1 (es) 2013-11-22 2016-12-02 Basf Se Compuestos heterocíclicos de n-acilimino
US9051320B1 (en) * 2014-08-18 2015-06-09 Pharmakea, Inc. Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
CN116059203A (zh) 2015-05-27 2023-05-05 赛博治疗有限责任公司 自分泌运动因子抑制剂及其用途

Similar Documents

Publication Publication Date Title
JPWO2023190748A5 (cg-RX-API-DMAC10.html)
JP2021502403A5 (cg-RX-API-DMAC10.html)
JP2020535134A5 (cg-RX-API-DMAC10.html)
JP2019031560A5 (cg-RX-API-DMAC10.html)
JP2020510664A5 (cg-RX-API-DMAC10.html)
JP2019131579A5 (cg-RX-API-DMAC10.html)
JP2021119158A5 (cg-RX-API-DMAC10.html)
CN107250149A (zh) 氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物
JP2018505203A5 (cg-RX-API-DMAC10.html)
JP2015535270A5 (cg-RX-API-DMAC10.html)
JP2017529389A5 (cg-RX-API-DMAC10.html)
JP2016199576A5 (cg-RX-API-DMAC10.html)
JP2019517491A5 (cg-RX-API-DMAC10.html)
JP2018534286A5 (cg-RX-API-DMAC10.html)
JP2021512114A5 (cg-RX-API-DMAC10.html)
JP2018516963A5 (cg-RX-API-DMAC10.html)
JP2019507777A5 (cg-RX-API-DMAC10.html)
UA101348C2 (ru) 1,2,4-оксадиазольные соединения для лечения аутоиммунных заболеваний
RU2018144774A (ru) Антагонист trpv4
WO2007122812A1 (ja) 炎症性腸疾患治療薬
JP2019527239A5 (cg-RX-API-DMAC10.html)
KR20190128619A (ko) 의약에서 사용하기 위한 술폭시알킬 오르가노니트로 및 관련 화합물 및 제약 조성물
JP2018514535A5 (cg-RX-API-DMAC10.html)
JP2023548055A5 (cg-RX-API-DMAC10.html)
JP2007504168A5 (cg-RX-API-DMAC10.html)